• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Prana Biotechnology Ltd

+ Add to Watchlist

PRAN:US

2.1000 USD 0.00000.00%

As of 20:10:00 ET on 08/22/2014.

Snapshot for Prana Biotechnology Ltd (PRAN)

Open: 2.1400 Day's Range: 2.0900 - 2.1500 Volume: 163,606
Previous Close: 2.1000 52wk Range: 1.4700 - 13.2900 1-Yr Rtn: -63.98%

Stock Chart for PRAN

No chart data available.
  • PRAN:US 2.1050
  • 1D
  • 1M
  • 1Y
2.1000
Interactive PRAN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PRAN

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2014) -0.2350
Est. PEG Ratio -
Market Cap (M USD) 102.68
Shares Outstanding (M) 48.89
30 Day Average Volume 952,767
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PRAN

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PRAN

Prana Biotechnology Limited is an Australian biotechnology company which researches and develops therapeutic drugs used for treatment of Alzheimer's Disease and other age-related degenerative disorders such as Parkinson's Disease and cataracts.

Geoffrey P KemplerChairman/CEO/FounderRichard RevelinsCFO/Secretary
Diane AngusChief Operating OfficerRudolph E Tanzi "Rudy"Chief Scientific Advisor
More Company Profile & Key Executives for PRAN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil